Paxlovid

Medicinal product

(Invented) name

Paxlovid

Active substance (s)

Nirmatrelviras+Ritonaviras

Strength

150 mg + 100 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AE30, nirmatrelvir and ritonavir

Marketing authorisation holder

Pfizer Europe MA EEIG, Belgija

Date of authorisation

2022-01-28

Date of renewal

Documents

EMA PAXLOVID DHPC-DDI_LT signed.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Rožinėje tabletėje yra	1 vnt.
Nirmatrelviras	150 mg
Baltoje tabletėje yra	1 vnt.
Ritonaviras	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107942	94047	1094047	lizdinė kortelė	N30 (20+10)		Receptinis	EU/1/22/1625/001	Tiekiama	2024-12-02	-	No	-	-
117481	103586	1103586	lizdinė kortelė	N11 (6+5)		Receptinis	EU/1/22/1625/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2022-01-28	Registruotas